Compass Therapeutics Inc (CMPX)
1.60
+0.06
(+3.90%)
USD |
NASDAQ |
May 16, 16:00
1.60
0.00 (0.00%)
After-Hours: 20:00
Compass Therapeutics 1 Year Total Returns (Daily): -53.61% for May 15, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 15, 2024 | -53.61% |
May 14, 2024 | -50.38% |
May 13, 2024 | -52.07% |
May 10, 2024 | -52.52% |
May 09, 2024 | -53.24% |
May 08, 2024 | -54.60% |
May 07, 2024 | -49.24% |
May 06, 2024 | -48.64% |
May 03, 2024 | -43.33% |
May 02, 2024 | -43.88% |
May 01, 2024 | -49.68% |
April 30, 2024 | -52.16% |
April 29, 2024 | -51.50% |
April 26, 2024 | -46.49% |
April 25, 2024 | -43.94% |
April 24, 2024 | -49.14% |
April 23, 2024 | -47.77% |
April 22, 2024 | -48.80% |
April 19, 2024 | -51.64% |
April 18, 2024 | -53.44% |
April 17, 2024 | -52.34% |
April 16, 2024 | -49.35% |
April 15, 2024 | -49.03% |
April 12, 2024 | -49.06% |
April 11, 2024 | -53.62% |
Date | Value |
---|---|
April 10, 2024 | -53.49% |
April 09, 2024 | -50.30% |
April 08, 2024 | -49.40% |
April 05, 2024 | -47.85% |
April 04, 2024 | -44.05% |
April 03, 2024 | -42.19% |
April 02, 2024 | -44.95% |
April 01, 2024 | -43.73% |
March 28, 2024 | -37.14% |
March 27, 2024 | -34.71% |
March 26, 2024 | -37.74% |
March 25, 2024 | -35.53% |
March 22, 2024 | -32.17% |
March 21, 2024 | -30.86% |
March 20, 2024 | -33.96% |
March 19, 2024 | -37.06% |
March 18, 2024 | -33.82% |
March 15, 2024 | -35.67% |
March 14, 2024 | -46.11% |
March 13, 2024 | -37.43% |
March 12, 2024 | -37.65% |
March 11, 2024 | -39.76% |
March 08, 2024 | -46.59% |
March 07, 2024 | -47.68% |
March 06, 2024 | -46.15% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-83.18%
Minimum
Apr 28 2022
165.9%
Maximum
Mar 08 2023
-7.92%
Average
-27.94%
Median
Aug 29 2022
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -44.62% |
AIM ImmunoTech Inc | -5.98% |
IGC Pharma Inc | 73.11% |
NovaBay Pharmaceuticals Inc | -86.38% |
Protalix BioTherapeutics Inc | -48.87% |